Rxsight share price today

(RXST)

Rxsight share price is $33.66 & ₹2,860.29 as on 21 Dec 2024, 2.30 'hrs' IST

$33.66

▲

-4.53

(-11.86%)

Market is closed - opens 8 PM, 23 Dec 2024

View live Rxsight share price in Dollar and Rupees. Guide to invest in Rxsight from India. Also see the sentimental analysis on Indian investors investing in Rxsight. Get details on the Indian mutual funds that are investing in Rxsight. Get Analyst recommendations and forecasts along with all the Rxsight's financials.

Rxsight share price movements

Today's Low: $33.04
Today's High: $35.75
$33.66
1.84%
Downside
Day's Volatility :7.58%
Upside
5.85%
52 Weeks Low: $33.03
52 Weeks High: $66.54
$33.66
1.87%
Downside
52 Weeks Volatility :50.36%
Upside
49.41%

Rxsight Returns

Period	Rxsight Inc	Index (Russel 2000)
3 Months	-34.72%	0.0%
6 Months	-39.64%	0.0%
1 Year	-14.78%	0.0%
3 Years	216.65%	-19.7%

Rxsight Key Statistics

in dollars & INR

Previous Close	$38.19
Open	$35.41
Today's High	$35.75
Today's Low	$33.04
Market Capitalization	$1.5B
Today's Volume	$2.2M
52 Week High	$66.54
52 Week Low	$33.03
Revenue TTM	$128.3M
EBITDA	$-35.0M
Earnings Per Share (EPS)	$-0.81
Profit Margin	-23.92%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-13.99%

How to invest in Rxsight from India?

It is very easy for Indian residents to invest directly in Rxsight from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Rxsight stock in both Indian Rupees (INR) and US Dollars (USD). Search for Rxsight or RXST on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Rxsight or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Rxsight shares which would translate to 0.025 fractional shares of Rxsight as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Rxsight, in just a few clicks!

Returns in Rxsight for Indian investors in Rupees

Investment Value

₹1,00,000

Rxsight investment value today

Current value as on today

₹1,16,981

Returns

₹16,981

(+16.98%)

Returns from Rxsight Stock

₹14,785 (false-14.78%)

Dollar Returns

₹2,196 (+2.2%)

Indian investors sentiment towards Rxsight

-14%

Period: Sep 22, 2024 to Dec 21, 2024. Change in 30 Days versus previous period

Search volume for Rxsight on INDmoney from India has reduced in the last 30 days as on Dec 22, 2024. -14% less investors are searching Rxsight in the last 30 days versus the previous period.

Global Institutional Holdings in Rxsight

RA Capital Management, LLC
9.72%
BlackRock Inc
5.96%
Vanguard Group Inc
5.67%
Bank of America Corp
4.33%
FMR Inc
2.98%
Artisan Partners Limited Partnership
2.90%

Analyst Recommendation on Rxsight

Buy

92%Buy

7%Hold

0%Sell

Based on 14 Wall street analysts offering stock ratings for Rxsight(by analysts ranked 0 to 5 stars)

Based on 14 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Rxsight

What analysts predicted

Upside of 79.74%

Current:

$33.66

Target:

$60.50

Insights on Rxsight

Price Movement
In the last 1 month, RXST stock has moved down by -25.3%
Increasing Revenue
Revenue is up for the last 4 quarters, 28.58M → 45.40M (in $), with an average increase of 13.9% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, -6.07M → -6.33M (in $), with an average decrease of 4.3% per quarter
RXST vs BSX (1 yr)
In the last 1 year, Boston Scientific Corp. has given 59.8% return, outperforming this stock by 73.0%
Price to Sales
ForRXST every $1 of sales, investors are willing to pay $9.9, whereas for Boston Scientific Corp., the investors are paying $8.2 for every $1 of sales.

Rxsight Financials in INR & Dollars

	FY19	Y/Y Change
Revenue	$2.2M	-
Net Income	$126.2M	-
Net Profit Margin	5.6K%	-

	FY20	Y/Y Change
Revenue	$14.7M	↑ 554.98%
Net Income	$27.6M	↓ 78.15%
Net Profit Margin	187.87%	↓ 5444.44%

	FY21	Y/Y Change
Revenue	$22.6M	↑ 53.92%
Net Income	$-48.7M	↓ 276.57%
Net Profit Margin	-215.5%	↓ 403.37%

	FY22	Y/Y Change
Revenue	$49.0M	↑ 116.9%
Net Income	$-66.8M	↑ 37.11%
Net Profit Margin	-136.22%	↑ 79.28%

	FY23	Y/Y Change
Revenue	$89.1M	↑ 81.77%
Net Income	$-48.6M	↓ 27.19%
Net Profit Margin	-54.57%	↑ 81.65%

	Q2 FY23	Q/Q Change
Revenue	$20.8M	↑ 18.99%
Net Income	$-13.8M	↓ 6.94%
Net Profit Margin	-66.33%	↑ 18.49%

	Q3 FY23	Q/Q Change
Revenue	$30.7M	↑ 47.37%
Net Income	$-12.4M	↓ 10.06%
Net Profit Margin	-40.48%	↑ 25.85%

	Q4 FY23	Q/Q Change
Revenue	$28.6M	↓ 6.81%
Net Income	$-9.2M	↓ 26.08%
Net Profit Margin	-32.11%	↑ 8.37%

	Q1 FY24	Q/Q Change
Revenue	$29.5M	↑ 3.26%
Net Income	$-9.1M	↓ 0.84%
Net Profit Margin	-30.83%	↑ 1.28%

	Q2 FY24	Q/Q Change
Revenue	$34.9M	↑ 18.21%
Net Income	$-6.1M	↓ 33.2%
Net Profit Margin	-17.42%	↑ 13.41%

	Q3 FY24	Q/Q Change
Revenue	$45.4M	↑ 30.16%
Net Income	$-6.3M	↑ 4.26%
Net Profit Margin	-13.96%	↑ 3.46%

	FY19	Y/Y Change
Profit	$-1.8M	-

	FY20	Y/Y Change
Profit	$1.7M	↓ 193.73%

	FY21	Y/Y Change
Profit	$4.5M	↑ 164.93%

	FY22	Y/Y Change
Profit	$21.3M	↑ 372.17%

	FY23	Y/Y Change
Profit	$53.8M	↑ 152.09%

	Q2 FY23	Q/Q Change
Profit	$12.0M	↑ 15.91%

	Q3 FY23	Q/Q Change
Profit	$13.7M	↑ 14.28%

	Q4 FY23	Q/Q Change
Profit	$17.7M	↑ 28.57%

	Q1 FY24	Q/Q Change
Profit	$20.7M	↑ 17.17%

	Q2 FY24	Q/Q Change
Profit	$24.3M	↑ 17.23%

	Q3 FY24	Q/Q Change
Profit	$25.2M	↑ 4.0%

	FY19	Y/Y Change
Operating Cash Flow	$-40.6M	-
Investing Cash Flow	$-5.9M	-
Financing Cash Flow	$1.3M	-

	FY20	Y/Y Change
Operating Cash Flow	$-35.2M	↓ 13.33%
Investing Cash Flow	$15.6M	↓ 365.6%
Financing Cash Flow	$25.2M	↑ 1797.52%

	FY21	Y/Y Change
Operating Cash Flow	$-44.7M	↑ 27.0%
Investing Cash Flow	$-81.9M	↓ 625.35%
Financing Cash Flow	$137.3M	↑ 444.21%

	FY22	Y/Y Change
Operating Cash Flow	$-58.9M	↑ 31.63%
Investing Cash Flow	$40.0M	↓ 148.77%
Financing Cash Flow	$6.3M	↓ 95.39%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-7.5M	↓ 57.52%
Investing Cash Flow	$4.4M	↓ 109.09%
Financing Cash Flow	$891.0K	↓ 98.64%

Rxsight Technicals Summary

Sell

Neutral

Buy

Rxsight is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Rxsight Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Rxsight Inc	-24.92%	-39.64%	-14.78%	216.65%	110.37%
Stryker Corporation	-6.55%	7.53%	21.91%	35.92%	72.32%
Boston Scientific Corp.	-2.79%	15.96%	58.87%	108.22%	96.31%
Edwards Lifesciences Corp.	6.29%	-17.03%	-1.93%	-41.81%	-4.82%
Abbott Laboratories	-2.58%	8.48%	4.58%	-17.91%	30.88%
Medtronic Plc	-4.38%	-0.01%	-1.54%	-21.25%	-28.78%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Rxsight Inc	NA	NA	NA	-0.12	-0.14	-0.1	NA	6.89
Stryker Corporation	38.32	38.32	2.51	12.06	0.19	0.07	0.01	52.86
Boston Scientific Corp.	73.27	73.27	1.61	2.46	0.09	0.05	NA	14.05
Edwards Lifesciences Corp.	28.88	28.88	6.79	2.55	0.19	0.11	NA	16.18
Abbott Laboratories	34.17	34.17	2.17	4.68	0.15	0.06	0.02	22.94
Medtronic Plc	24.46	24.46	1.46	5.2	0.08	0.04	0.03	38.29

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Rxsight Inc	Buy	$1.5B	110.37%	NA	-23.92%
Stryker Corporation	Buy	$136.1B	72.32%	38.32	16.34%
Boston Scientific Corp.	Buy	$130.7B	96.31%	73.27	11.26%
Edwards Lifesciences Corp.	Buy	$44.1B	-4.82%	28.88	65.86%
Abbott Laboratories	Buy	$195.0B	30.88%	34.17	13.99%
Medtronic Plc	Buy	$102.6B	-28.78%	24.46	12.06%

Rxsight Dividend announcements

Rxsight Earnings
Rxsight’s price-to-earnings ratio stands at None
Read More

About Rxsight

calhoun vision is the world leader in adjustable intraocular lens technology. the company's proprietary technology utilizes light to enable surgeons to change the power of a lens after it has been implanted in the eye. this offers the potential to provide unparalleled visual outcomes and customization to the specific visual needs of each patient. calhoun vision's light adjustable lens technology is an investigational device in the united states and requires fda approval before it can be marketed commercially. the company has completed phases i and ii of the required clinical investigation; the third and final phase of study has commenced, and all subjects have been fully enrolled.

Organization	Rxsight
Employees	374
CEO	Dr. Ronald M. Kurtz M.D.
Industry	Miscellaneous

Management People of Rxsight

Name	Title
Dr. Ronald M. Kurtz M.D.	President, CEO & Director
Mr. Eric J. Weinberg	Co-President & Chief Commercial Officer
Ms. Shelley B. Thunen	Co-President & Chief Financial Officer
Dr. Ilya Goldshleger Ph.D.	Co-President & Chief Operating Officer
Ms. Rebecca Williston	Vice President of Accounting & Finance
Mr. Matt Haller Ph.D.	Chief Technology Officer
Mr. Oliver Moravcevic	Vice President of Investor Relations
Mr. Steve Everly	Senior VP of Sales of North America
Mr. Roy Freeman	Senior VP of Marketing & Professional Relations
Ms. Caroline Vaughn	Vice President of Human Resources

Important FAQs about investing in Rxsight from India :

What is Rxsight share price today?

Rxsight share price today stands at $33.66, Open: $35.41 ; Previous Close: $38.19 ; High: $35.75 ; Low: $33.04 ; 52 Week High: $66.54 ; 52 Week Low: $33.03. The stock opens at $35.41, after a previous close of $38.19. The stock reached a daily high of $35.75 and a low of $33.04, with a 52-week high of $66.54 and a 52-week low of $33.03.

Can Indians buy Rxsight shares?

Yes, Indians can invest in the Rxsight (RXST) from India.

With INDmoney, you can buy Rxsight at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Rxsight at zero transaction cost.

How can I buy Rxsight shares from India?

It is very easy to buy Rxsight from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Rxsight be purchased?

Yes, you can buy fractional shares of Rxsight with INDmoney app.

What are the documents required to start investing in Rxsight stocks?

To start investing in Rxsight, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.